Skip to content

Decompression vs. Fusion for Stable Degenerative Spondylolisthesis

Decompression Alone vs. Decompression and Instrumented Fusion for the Management of Lumbar Spinal Stenosis Associated With Stable Degenerative Spondylolisthesis: A Pragmatic Randomized Clinical Pilot Trial

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02348645
Enrollment
70
Registered
2015-01-28
Start date
2015-07-01
Completion date
2023-08-01
Last updated
2026-05-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Spinal Stenosis, Spondylolisthesis

Keywords

Pilot projects, Feasibility studies, Intervention studies, Orthopedics, Orthopedic Procedures, Neurosurgical Procedures, Neurosurgery, Spine, Spinal Fusion, Spondylodesis, Spondylosyndesis, Laminectomy, Foraminotomy, Decompression, surgical, Low Back Pain, Quality of Life

Brief summary

The purpose of this study is to assess the feasibility of a full-scale multicenter randomized, controlled trial comparing the effectiveness of two surgical treatments for a condition associated with lumbar spinal stenosis called degenerative lumbar spondylolisthesis. Both treatments are currently used, but individual surgeons use different selection criteria for each treatment and use the procedures at different rates. The two procedures are decompression with fusion (the most common surgical procedure for spondylolisthesis) and midline-sparing decompression alone (which is also a standard treatment, but is not as widely used for treating spondylolisthesis). The investigators plan to collect the evidence on the following: 1. The feasibility of the trial protocol, and 2. Preliminary data on the effectiveness of each treatment.

Interventions

PROCEDURESpinal fusion

Sponsors

University Health Network, Toronto
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
50 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients deemed to be surgical candidates with focal (1-2 level) lumbar spinal stenosis (LSS) and associated stable degenerative spondylolisthesis with the following characteristics: 1. a clinical history of back, buttock and leg pain with walking or standing that is improved when lying, sitting or bending forward 2. a clinical history of leg symptoms that are greater than or equal to back symptoms with walking or standing, and 3. greater than 6 months of symptoms with failed conservative care * aged 50 or over * sufficient fluency in English or French to provide informed consent and complete questionnaires with or without the need of an interpreter

Exclusion criteria

* Greater than 25% listhesis or spinal instability as demonstrated by motion (\>5mm of translation) on flexion extension radiographs or non-loaded (MRI/CT or supine x-rays) to loaded imaging (standing radiograph) * Presence of kyphosis (\>0 degrees at the affected level or globally), degenerative scoliosis (\>10 degree using the Cobb method) with rotatory or lateral listhesis on preoperative x-rays * Clinical history of osteoporotic fracture or chronic oral steroid use * Previous posterior lumbar spinal surgery (excluding prior microdiscectomy) * Patients who have evidence of neurological disorders that affect physical function (e.g. peripheral neuropathy), neuromuscular disorders (e.g. multiple sclerosis, Parkinson's etc.) or systemic illness (e.g. inflammatory arthritis) that affects physical function

Design outcomes

Primary

MeasureTime frameDescription
Number of patients recruited1 year
Number of eligible patients1 year
Reasons for refusal to consent1 year
Proportion of patients who adhere to randomized allocation2 years
Number of patients refusing to consent due to blinding1 year
Blinding status1.5 months post-surgeryPatient's assessment of which treatment they received
Oswestry Disability Index (ODI)6-18 weeks, 6 months (optional), 12 months, and 24 months post-surgery10-item patient-reported questionnaire measuring disability related to low back pain. Each item has six response options ranging from 0 to 5; the responses are summed and rescaled so 0 indicates no disability and 100 indicates extreme disability.
Proportion of patients who receive randomized allocation2 years
Number of patients refusing to consent due to randomization1 year
Number, type and severity of adverse eventsEnd of hospital stay (average 6.5 days post-surgery)

Secondary

MeasureTime frameDescription
Short-Form 12 scores: Physical Function, Bodily Pain, Physical Component SummaryBaseline; 6-18 weeks, 6 months (optional), 12 months, and 24 months post-surgery12-item patient-reported questionnaire for general health status based on the SF-36 Health Survey (version 2). Measures eight health domains, each scored so 0 is the worst and 100 is the best possible score: general health (GH), physical function (PF), bodily pain (BP), role limitations due to physical problems (RP), role limitations due to emotional problems (RE), mental health (MH), social functioning (SF), and energy/fatigue (VT). The domain scores can be aggregated into Physical Component Summary (PCS) and Mental Component Summary (MCS) scores, also scaled so 0 is the worst and 100 is the best possible score. This study will focus primarily on the Physical Function domain, the Bodily Pain domain, and the Physical Component Summary score.
Euro-QoL health utility indexBaseline; 6-18 weeks, 6 months (optional), 12 months, and 24 months post-surgeryPatient-reported questionnaire for general health state which includes five items (mobility, self-care, usual activities, pain/discomfort, and anxiety/depression) and a visual analog scale for self-rated health state. Using an existing U.S. population-based value set, responses will be converted to the corresponding health utility index (1.0=perfect health and 0.0=death).
Patient Health Questionnaire-9 scoreBaselinePatient-reported questionnaire that measures severity of depression symptoms. It is scored from 0 to 27, with the following interpretation: 0-4=no symptoms, 5-9=minimal symptoms; 10-14=mild/minor depression or dysthymia; 15-19=moderate major depression; 20-27=severe major depression.
Costs incurred by patientsmonthly from 1.5 to 12 months post-surgery; 24 months post-surgery
Hospital costEnd of hospital stay (average 6.5 days post-surgery)
Healthcare services usedReferral to 1 year post-surgeryOther Ontario Health Insurance Plan (OHIP)-billed services used

Countries

Canada

Contacts

PRINCIPAL_INVESTIGATORYoga Raja Rampersaud, MD FRCSC

University Health Network, Toronto

PRINCIPAL_INVESTIGATORAnthony Perruccio, PhD

University Health Network, Toronto

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 8, 2026